Fig. 1From: Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective studyPrevalence of mucormycosis-related hospitalizations. Note: [1] Mucormycosis encounters with drug restriction were identified using ICD-9 codes or laboratory results and required at least one use of amphotericin B or posaconazoleBack to article page